Nothing added, nothing removed Loaded with natural marine nutrients

The features of our fresh raw material enables us to use a gentle processing method, simply extracting the lipids – as is – from the rest of the components. Due to its unique chemistry, it is not necessary to refine, concentrate or change the composition in anyway. This provides a complex and broad lipid profile of the oil obtained.

Graphical overview of the diverse composition of Zooca™ Lipids, as a result of the gentle manufacturing process.

A special combination

The special combination of the three omega-3 polyunsaturated fatty acids SDA, EPA and DHA are due to the phytoplankton fatty acids being incorporated into the copepods’ storage lipids. Therefore, the fatty acids found in Zooca™ Lipids are largely reflected by the fatty acid composition of the phytoplankton. The high content of the long-chain monounsaturated fatty acids and their corresponding long-chain policosanols in Zooca™ Lipids are the results of the copepods’ own synthesis.

As Zooca™ Lipids is a non-refined lipid extract from a natural source, it contains a plethora of different lipid components such as astaxanthin, policosanols and more than 15 different fatty acids, as illustrated in the figure.

A man holding a vial of Lipids
Zooca products for animal and people


The wax esters in Zooca™ Lipids contain bioactive lipid molecules which resemble long-chain monounsaturated fatty acids. These are often referred to as policosanols due to its alcohol moiety (-ols). Nearly 40 % of the Zooca™ Lipids are present as the policosanols eicosenol (20:1 n-9) and docosenol (22:1 n-11), which constitute the major part of the alcohol fraction. These special biomolecules are entirely made from de novo biosynthesis by the zooplankton.  Initially, the fatty acids are built and subsequently reduced to the corresponding policosanol. 

Long-chain alcohols from terrestrial sources such as rice bran wax and sugar cane wax have been shown to increase physical performance and exert anti-inflammatory effects. It has been suggested that the long-chain fatty alcohols enhance physical performance through sparing of muscle glycogen stores by increasing the lipid oxidation (Taylor et al., 2003). However, there are few studies on the effects of marine fatty alcohols and further investigation is thus required. 


Decades of research support that higher intake of EPA and DHA is associated with reduced risk of mortality from coronary heart disease and sudden cardiac death (Innes and Calder, 2020). In addition to EPA and DHA, Zooca™ Lipids is especially rich in stearidonic acid (SDA). This is the first metabolite formed directly from alpha-linolenic acid (ALA, 18:3 n-3, Figure 3), which is poorly converted to EPA and DHA in t

Understandable science puts you in control

As the first ones in the world, we are persistently working on research and development, documenting the potential of the valuable bioactive components from this unique resource. 

The different product streams derived from Calanus finmarchicus now have a solid track record of documentation – providing insight to the different areas of impact. For humans and animals alike. 

Strong scientific foundation - Zooca Lipids

Clinical and preclinical studies so far have been focusing on screening for effects and mechanisms in humans to document safety and uptake. Since the beginning of the scientific exploration, the volume of scientific publications and theses are continuously growing. So far, ten doctoral candidates have been involved in Zooca™ Lipids research, and numerous peer-reviewed papers have been produced in the areas of biomedical and biochemical science. The findings so far have attracted much attention.

Safety and bioavailability have been documented in several human studies. The bioavailability study showed that Zooca™ Lipids gives a twofold uptake compared to ethyl esters, confirming that the Zooca lipids are digested, and its fatty acids absorbed (Cook et al., 2016) and a recently conducted study  confirmed these data by revealing a remarkable 21% increase in the omega-3 index (sum of EPA and DHA in red blood cells) from a 12 week intervention (Wasserfurth et al., 2021 and Burhop et al 2022). 

Several doctoral students and researchers are engaged in ongoing projects related to mechanistic and preclinical studies, as well as clinical trials directly related to the impact of Zooca™ Lipids. The Zooca™ Company is currently involved in several human clinical trials within the areas of metabolic health and a big intervention study on children with ADHD.

Future studies will become increasingly more targeted towards specific effects, and the long-term goal is to qualify for one or more approved health claims in the EU and other markets.

Human health

Good for the heart

Good for eye health

Good for the muscles

Good for the immune system

Animal nutrition

Good for growth

Good for survival

Good for taste

Good as whole